ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

ClinicalTrials.gov ID: NCT01321541

Public ClinicalTrials.gov record NCT01321541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 2:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Multicenter Study Comparing Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed After Therapy With CHOP-R or an Equivalent Regimen and Are Ineligible for Stem Cell Transplant

Study identification

NCT ID
NCT01321541
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
312 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 19, 2011
Primary completion
Jun 27, 2018
Completion
Sep 13, 2018
Last update posted
Nov 18, 2021

2011 – 2018

United States locations

U.S. sites
51
U.S. states
23
U.S. cities
42
Facility City State ZIP Site status
Arizona Clinical Research Center Tucson Arizona 85715
Arizona Oncology Associates Tucson Arizona 85745
Highlands Oncology Group Bentonville Arkansas 72712
Highlands Oncology Group Fayetteville Arkansas 72703
Rocky Mountain Cancer Centers Aurora Colorado 80012
Rocky Mountain Cancer Centers Boulder Colorado 80303
Rocky Mountain Cancer Centers Denver Colorado 80218
George Washington University Department of Medicine Washington D.C. District of Columbia 20037
Integrated Community Oncology Network-St. Vincent's Jacksonville Florida 32204
Integrated Community Oncology Network-Southside Jacksonville Florida 32207
Integrated Community Oncology Network Orange Park Florida 32073
Carle Physician Group Danville Illinois 61832
Cancer Care Specialists of Central Illinois Decatur Illinois 62526
Crossroads Cancer Center Effingham Illinois 62401
Carle Foundation Physician Services Mattoon Illinois 61938
Carle Cancer Center Urbana Illinois 61801
Cancer Center of Kansas Wichita Kansas 67208
Cancer Center of Kansas Wichita Kansas 67215
Baptist Hospital East Louisville Kentucky 40207
Harry and Jeanette Weinberg Cancer Institute at Franklin Square Baltimore Maryland 21237
Center for Cancer and Blood Disorders, PC Bethesda Maryland 20817
Cancer & Hematology Center of Western Michigan Grand Rapids Michigan 49450
Metro Minnesota CCOP-Unity Hospital Fridley Minnesota 55432
Metro Minnesota CCOP-St. Johns Maplewood Minnesota 55109
Metro Minnesota Community Clinical Oncology Program Saint Louis Park Minnesota 55416
Metro Minnesota Community Clinical Oncology Program Saint Louis Park Minnesota 55426
Metro Minnesota CCOP-Regions Hospital Saint Paul Minnesota 55101
Missouri Cancer Associates Columbia Missouri 65201
Nebraska Hematology-Oncology, PC Lincoln Nebraska 68506
Hematology-Oncology Associates of Northern New Jersey Morristown New Jersey 07962
North Shore Hematology/Oncology Associates East Setauket New York 11733
Gabrail Cancer Center Canton Ohio 44718
Gabrail Cancer Center Dover Ohio 44622
Toledo Clinical Cancer Center Toledo Ohio 43617
Mercy Cancer Center at St. Anne's Toledo Ohio 43623
Toledo Clinic Cancer Center-Toledo Toledo Ohio 43623
Northwest Cancer Specialists, PC Portland Oregon 97213
Northwest Cancer Specialists, PC Portland Oregon 97225
Northwest Cancer Specialists, PC Tualatin Oregon 97062
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Upstate Oncology Associates Greenville South Carolina 29615
South Carolina Cancer Specialists Hardeeville South Carolina 29927
South Carolina Cancer Specialists Hilton Head Island South Carolina 29926
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410
Cancer Care Centers of South Texas-HOAST New Braunfels Texas 78130
Cancer Care Centers of South Texas-HOAST San Antonio Texas 78229
Blue Ridge Cancer Care Roanoke Virginia 24014
Northwest Cancer Specialists, PC Vancouver Washington 98684
Northwest Cancer Specialists, PC Vancouver Washington 98686
Saint Vincent Hospital Green Bay Oncology Green Bay Wisconsin 54301
Green Bay Oncology-St. Mary's Hospital MC Green Bay Wisconsin 54303

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01321541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2021 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01321541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →